openPR Logo
Press release

Respiratory Syncytial Virus (RSV) Market Size, Share, Industry, Forecast and outlook (2024-2031)

02-23-2024 11:54 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

DataM Intelligence

DataM Intelligence

Respiratory Syncytial Virus (RSV) Market

Global Respiratory Syncytial Virus (RSV) Market Set to Double in Size, Reaching USD 2.4 Billion by 2030

The global Respiratory Syncytial Virus (RSV) market, which achieved a notable USD 1.2 billion valuation in 2022, is poised for substantial growth, projected to reach USD 2.4 billion by 2030. A comprehensive market analysis indicates a robust Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period spanning 2024 to 2031. The surge is primarily attributed to the expanding elderly population globally.

Key growth drivers for the Respiratory Syncytial Virus (RSV) therapeutics market include an escalating incidence of RSV infections in infants and young children, enhanced treatment options, and a substantial presence of hospitals and specialty clinics. According to the World Health Organization (WHO), by 2030, one in six individuals globally will be 60 or older, creating a favorable landscape for the market's expansion.

Market Scope and Metrics:

CAGR: 10.2%
Forecast Period: 2024-2031
Size Available for Years: 2021-2030
Segments Covered: Drug Type, Dosage Form, Treatment Type, Distribution Channel, and Region
Regions Covered: North America, Europe, Asia-Pacific, South America, and Middle East & Africa
Fastest Growing Region: Asia-Pacific
Largest Region: North America
Report Insights Covered:
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Type Launches, Growth Strategies, Revenue Analysis, Porter's Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Orthopedic Surgery key Insights.

To know more Insights Download Sample: https://www.datamintelligence.com/download-sample/respiratory-syncytial-virus-market

Market Dynamics:

Increasing Prevalence of RSV is a Key Factor Helping Market Expansion

Respiratory Syncytial Virus (RSV) is a common respiratory virus affecting young children and causing mild to severe respiratory diseases. RSV infections, prevalent in autumn, winter, and early spring, are a leading cause of lower respiratory tract infections in newborns and young children. The rise in RSV incidents, especially among infants and the elderly, is a significant factor propelling market growth.

Rise in Clinical Trials by Key Players Expected to Drive Market Growth

Key players' increased focus on clinical trials is expected to fuel market expansion. Notably, the Nirsevimab medication, developed by Sanofi and AstraZeneca, demonstrated an 83% reduction in RSV baby hospitalizations during a real-world clinical trial. Pfizer also reported positive results from its MATISSE Phase 3 clinical trial for the RSV prefusion vaccine candidate.

High Cost of Disease Management to Hamper Market Growth

The considerable cost of managing RSV, with expenses such as palivizumab ranging from $1,660 to $2,500 per dose, is anticipated to hinder market expansion. The substantial financial burden may impede the global RSV market's growth.

Market Segment Analysis:

The Nirsevimab Segment Expected to Hold Dominant Position

The Nirsevimab segment, a monoclonal antibody targeting respiratory syncytial virus, is projected to dominate the market, accounting for approximately 31.20% in 2022. Product approvals by regulatory bodies and an increasing number of clinical trials are expected to drive segment expansion.

Geographical Share:

North America Holds Dominant Position

North America is estimated to hold about 39.4% of the total market share throughout the forecast period. The region's growing burden of RSV infections, coupled with robust research and development activities, increasing investments, and government initiatives, positions North America as a key driver for the global Respiratory Syncytial Virus (RSV) therapeutics market.

Related Reports:

hematuria treatment market: https://www.datamintelligence.com/research-report/hematuria-treatment-market
beri beri treatment market: https://www.datamintelligence.com/research-report/beri-beri-treatment-market
pellagra treatment market: https://www.datamintelligence.com/research-report/pellagra-treatment-market
klinefelter syndrome treatment market: https://www.datamintelligence.com/research-report/klinefelter-syndrome-treatment-marketacute intermittent porphyria market: https://www.datamintelligence.com/research-report/acute-intermittent-porphyria-market
vertigo treatment market: https://www.datamintelligence.com/research-report/vertigo-treatment-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Respiratory Syncytial Virus (RSV) Market Size, Share, Industry, Forecast and outlook (2024-2031) here

News-ID: 3397039 • Views:

More Releases from DataM Intelligence 4Market Research

IV Bags Market Set for Strong Growth as Hospital Admissions and Infusion Therapies 2025-2032 | Top Companies - Baxter, Pfizer, Inc., Fresenius Kabi AG, JW Life Science.
IV Bags Market Set for Strong Growth as Hospital Admissions and Infusion Therapi …
Market Overview: The IV Bags Market is expected to grow at a CAGR of 5% during the forecasting period 2024-2031. The IV Bags Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it
Feed Electrolytes Market is expected to reach US$ 28.3 billion by 2032 | Major players - Royal DSM, Tanke Biosciences Corp, BASF SE, DuPont.
Feed Electrolytes Market is expected to reach US$ 28.3 billion by 2032 | Major p …
Market Size and Growth: The Global Feed Electrolytes Market size reached US$ 3.64 billion in 2024 and is expected to reach US$ 28.3 billion by 2032, growing with a CAGR of 5.7% during the forecast period 2024-2032. The Feed Electrolytes Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed
Used Cooking Oil Market Set to Explode as Governments Push Circular Biofuel Solutions 2025-2032 | Major players - Georgia-Pacific Chemicals LLC, Kraton Corporation, Eagle Imports.
Used Cooking Oil Market Set to Explode as Governments Push Circular Biofuel Solu …
Market Overview: The Used Cooking Oil Market is expected to reach at a CAGR of 7.4% during the forecast period 2024-2031. The Used Cooking Oil Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research
Anionic Surfactant Market is expected to reach US$ 24.3 billion by 2032 | Major players - SNF Floerger, Kemira Oyj, BASF SE, Ecolab Inc.
Anionic Surfactant Market is expected to reach US$ 24.3 billion by 2032 | Major …
Market Size and Growth: The Global Anionic Surfactant Market size reached US$ 14.7 billion in 2024 and is expected to reach US$ 24.3 billion by 2032, growing with a CAGR of 6.4% during the forecast period 2025-2032. The Anionic Surfactant Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed

All 5 Releases


More Releases for RSV

The Rise In The Prevalence Of RSV Infection : A Key Catalyst Accelerating Global …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Respiratory Syncytial Virus (RSV) Therapeutics Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market encompassing therapeutics for respiratory syncytial virus (rsv) has witnessed substantial, rapid expansion lately, projected to increase its valuation from $1.6 billion in 2024 to $2 billion just one year later
The Rise In The Prevalence Of RSV Infection : Transformative Forces Shaping the …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Respiratory Syncytial Virus (RSV) Therapeutics Industry Market Size Be by 2025? The market size for therapeutics treating the respiratory syncytial virus (RSV) has seen significant expansion in the past few years. It is expected to surge from $1.6 billion in 2024 to $2 billion in 2025,
RSV Vaccine Market To Reach 731 million by 2040, Due To Increasing Awareness on …
According to our latest market report "RSV Vaccine Market, Till 2040 by Type of Vaccine, Route of Administration, Target Patient Population, Distribution Channel, Key Geographical Regions and Leading Players", the RSV Vaccine market size is projected to reach USD 731 million by 2040 from USD 1,149 million in current year, during the forecast period. To request quote of this report, please visit: https://www.rootsanalysis.com/reports/rsv-vaccine-market/request-quote.html In the dynamic landscape of preventive therapies for respiratory
Global RSV Diagnostic Products Market Size & Trends
According to a new market research report published by Global Market Estimates, the global RSV diagnostic products market is expected to grow at a CAGR of 11.4% from 2023 to 2028. Ongoing advancements in diagnostic technologies, specifically PCR and rapid point-of-care testing, play a crucial role. These advancements offer heightened accuracy, faster results, and increased accessibility, enabling prompt and precise identification of RSV infections. Browse 147 Market Data Tables and 115 Figures
Respiratory Syncytial Virus (RSV) Therapeutics Market Size to Reach USD 9080.84 …
Respiratory Syncytial Virus (RSV) Therapeutics Market Scope & Overview Respiratory Syncytial Virus (RSV) Therapeutics Market size was USD 1040.65 Million in 2022 and is expected to Reach USD 9080.84 Million by 2030 and grow at a CAGR of 31.1% over the forecast period of 2023-2030. The Respiratory Syncytial Virus (RSV) Therapeutics market is a vibrant, fiercely competitive sector that is essential to digital marketing. The demand for effective has increased as companies
Respiratory Syncytial Virus (RSV) Therapeutics Market - Conquering RSV: Advancin …
Newark, New Castle, USA: The "Respiratory Syncytial Virus (RSV) Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Respiratory Syncytial Virus (RSV) Therapeutics Market: https://www.growthplusreports.com/report/respiratory-syncytial-virus-rsv-therapeutics-market/8519 This latest report